AQST
Aquestive Therapeutics, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$3.97
+2.32%Margins
Gross margin
57.2%
EBITDA margin
-132.7%
EBIT margin
-114.1%
Net margin
-162.3%
FCF margin
-83.3%
111.9%
Return on equity
-66.4%
Return on assets
88.7%
Return on invested capital
0.39x
Asset turnover
-$39.8M
Cash from operations
$0.72
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026